Breast cancer 1985. What have we learned?

Area of Science:

• Oncology
• Surgical Oncology
• Medical Oncology

Background:

• A common misconception is that all breast cancers are systemic from the outset, and that primary treatment variations do not impact prognosis.
• Recent decades have seen moderate improvements in long-term breast cancer survival, largely due to earlier detection of early-stage disease.

Purpose of the Study:

• To clarify the impact of early detection and primary therapy on breast cancer prognosis.
• To differentiate the roles of local control and systemic therapy in long-term breast cancer outcomes.

Main Methods:

• Review of patient data over three decades focusing on early-stage breast cancer (Stage I) with localized or minimal axillary involvement.
• Analysis of long-term survival rates in relation to primary treatment achieving local control and the use of adjuvant multichemotherapy.

Main Results:

• Patients with early-stage breast cancer and minimal risk of systemic spread can achieve long-term disease-free survival with adequate primary therapy and local control.
• Aggressive primary therapy leading to total local control is crucial for sustained disease-free survival, with most patients remaining disease-free 15 years post-treatment.
• Adjuvant multichemotherapy has shown a positive effect on disease-free survival but has had a marginal impact on overall long-term patient survival.

Conclusions:

• Optimal breast cancer management hinges on early detection and aggressive primary therapy for complete local control.
• Systemic therapy is most beneficial for patients identified as having a high risk of occult systemic disease.